Neurology & NeurosurgeryBrain Tumor Surgery

Neuro-oncology

Brain Tumor Surgery in Germany: Multidisciplinary Review, Biopsy and Resection

Understand how German neuro-oncology and neurosurgery teams approach brain tumors, including multidisciplinary review, biopsy, resection and treatment planning.

By Treat in Germany Editorial TeamSources reviewed: 2026-08-29Independent clinician review: not yet claimed
Short answer: There is no single operation that applies to every brain tumor. Treatment depends on the tumor type, location, growth pattern, neurological function, molecular diagnosis and the patient’s overall condition. A specialist center may recommend observation, biopsy, surgical resection, radiotherapy, systemic treatment or a combination. The correct first step is a multidisciplinary review of imaging and pathology rather than assuming that a visible lesion should automatically be removed.

Why multidisciplinary review matters

Brain-tumor decisions often require neurosurgery, neuroradiology, neuropathology, radiation oncology, neurology and medical oncology. Freiburg describes weekly brain-tumor conferences where these disciplines review cases together before defining a treatment plan.

Biopsy and resection answer different questions

A stereotactic biopsy may be used when tissue diagnosis is needed but a larger resection is not appropriate or when the lesion is in a high-risk location. Resection aims to remove as much tumor as can be done safely when surgery is expected to improve diagnosis, symptom control or oncological treatment.

Modern planning focuses on preserving function

Neurosurgical planning can use MRI-based navigation, functional imaging, electrophysiological monitoring, intraoperative imaging and other techniques to understand the relationship between the tumor and critical brain networks. The goal is not simply maximum removal at any cost, but an individualized balance between tumor control and neurological safety.

Pathology and molecular diagnosis guide the next treatment

The surgical specimen is often only the beginning of the oncology pathway. Histological and molecular classification can affect radiotherapy, systemic treatment, clinical-trial eligibility and follow-up. Ask how pathology will be reviewed and how the post-operative plan will be coordinated.

Records to prepare for a German neuro-oncology review

Send the most complete diagnostic package available so the center can decide whether biopsy, resection or another approach should be discussed.

  • Recent MRI brain images in original DICOM format when requested
  • Radiology reports and earlier scans for comparison
  • Pathology report and molecular results if biopsy or surgery was already performed
  • Operative and discharge reports from prior neurosurgery
  • Current neurological symptoms and medications
  • Previous radiotherapy or systemic-treatment details

Official sources

Sources last checked 2026-08-29. Clinical pathways, eligibility and hospital procedures can change; confirm current requirements directly with the treating center.

Medical information notice: This page provides general educational information and does not diagnose disease or recommend an individual operation. Urgent neurological symptoms require timely local medical assessment.
Verified treatment centers

German centers documenting this treatment

These are not rankings or paid recommendations. Each center is included because its official website documents the relevant treatment or specialist program. Availability for an individual patient still requires medical review.